Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot2 - STU 1 ballot International flag

Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot2 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions

Example ArtifactAssessment: Certainty of Evidence Rating of 14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY)

Page standards status: Informative

version: 10; Last updated: 2025-08-14 14:13:53+0000

Profiles: CertaintyOfEvidence, EvidenceAssessment

Artifact Description:

This example of a CertaintyOfEvidence Profile shows a recursive pattern of component elements with type/classifier paired values for different aspects of rating the certainty of evidence.

ArtifactPublicationStatus: Active

identifier: FEvIR Object Identifier/179693

title: Certainty of Evidence Rating of 14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY)

citeAs:

Certainty of Evidence Rating of 14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY) [Database Entry: FHIR ArtifactAssessment Resource]. Contributors: In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 179693. Revised 2025-08-14. Available at: https://fevir.net/resources/ArtifactAssessment/179693. Computable resource at: https://fevir.net/resources/ArtifactAssessment/179693#json.

artifact: 14-day mortality remdesivir vs placebo meta-analysis (ACTT-1, Wang et al, WHO SOLIDARITY)

content

type: Rating System

classifier: GRADE

freeToShare: true

content

type: Overall certainty

classifier: Low quality

freeToShare: true